Substance P | CAS:33507-63-0

We serve Substance P CAS:33507-63-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Substance P

Chemical Name:Substance P
CAS.NO:33507-63-0
Synonyms:Substance P
neuropeptide substance P
RPKPQQFFGLM-NH2
RPKPQQFFGLM
N-(Diaminomethylene)-L-ornithyl-L-prolyl-L-lysyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-phenylalanyl-L-phenylalanylglycyl-L-leucyl-L-methioninamide
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Molecular Formula C63H98N18O13S
Molecular Weight 1347.630
Index of Refraction 1.663
 
Specification:
Appearance:White to off-white powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Substance P is a neuropeptide, acting as a neurotransmitter and as a neuromodulator.The endogenous receptor for substance P is neurokinin 1 receptor (NK1-receptor, NK1R).



Contact us for information like Substance P chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(Diaminomethylene)-L-ornithyl-L-prolyl-L-lysyl-L-prolyl-L-glutaminyl-L-glutaminyl-L-phenylalanyl-L-phenylalanylglycyl-L-leucyl-L-methioninamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,RPKPQQFFGLM-NH2 Use and application,RPKPQQFFGLM-NH2 technical grade,usp/ep/jp grade.


Related News: The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.2-methoxy-5-nitrobenzenediazonium manufacturer The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.3-Amino-6-bromopyridine supplier There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.6-chloropyridine-3-carbonitrile vendor There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.Resonant exploits its proprietary IMPaCT tumor microenvironment models and data platform to discover novel, unappreciated targets and functionally active anti-tumor antibodies for difficult to treat tumors.